Proof of Concept: Matrix metalloproteinase inhibitor decreases inflammation and improves muscle insulin sensitivity in people with type 2 diabetes
<p>Abstract</p> <p>Background</p> <p>Obesity is a state of subclinical inflammation resulting in loss of function of insulin receptors and decreased insulin sensitivity. Inhibition of the inflammatory enzymes, matrix metalloproteinases (MMPs), for 6 months in rodent mod...
Main Authors: | Frankwich Karen, Tibble Courtney, Torres-Gonzalez Moises, Bonner Mariah, Lefkowitz Roy, Tyndall Matt, Schmid-Schönbein Geert W, Villarreal Francisco, Heller Mike, Herbst Karen |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2012-10-01
|
Series: | Journal of Inflammation |
Subjects: | |
Online Access: | http://www.journal-inflammation.com/content/9/1/35 |
Similar Items
-
Role of matrix metalloproteinase in the aneurismatic aortic disease
by: Nicola Troisi, et al.
Published: (2004-09-01) -
Matrix Metalloproteinases as Biomarkers of Atherosclerotic Plaque Instability
by: Wioletta Olejarz, et al.
Published: (2020-05-01) -
Doxycycline inhibits matrix metalloproteinase-9 and laminin degradation after transient global cerebral ischemia
by: Hyung Lee, et al.
Published: (2009-05-01) -
The effect of laser irradiation and doxycycline application on the production of matrix metalloproteinase-8 and collagen I from cultured human periodontal ligament cells
by: Alireza Dehdashtizadeh, et al.
Published: (2020-01-01) -
Curcumin effects on myeloperoxidase, interleukin-18 and matrix metalloproteinase-9 inflammatory biomarkers in patients with unstable angina: A randomized clinical trial
by: Amir hooshang Mohammad pour, et al.
Published: (2019-08-01)